Logos Global Management LP Reata Pharmaceuticals Inc Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$22.15 - $42.11 $3.99 Million - $7.58 Million	180,000 New	180,000 $6.84 Million
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $18.7 Million - $32.7 Million	-200,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $14.9 Million - $20.8 Million	117,708 Added 143.04%	200,000 $31.2 Million
Q1 2020 May 15, 2020	BUY	$124.16 - $247.74 $3.3 Million - $6.59 Million	26,592 Added 47.74%	82,292 $11.9 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $4.15 Million - $12.1 Million	55,700 New	55,700 $11.4 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.